Proof of concept studies for siRNA delivery by nonionic surfactant vesicles: in vitro and in vivo evaluation of protein knockdown

References

• Al Qaraghuli, M.M., et al., 2017. Where traditional drug discovery meets modern technology in the quest for new drugs. Annals of pharmacology and pharmaceutics, 2 (11), 1–5.
   Google Scholar
• Contag, C.H., et al., 1997. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochemistry and photobiology, 66 (4), 523–531.
   PubMed Web of Science ®Google Scholar
• Dickins, R.A., et al., 2007. Tissue-specific and reversible RNA interference in transgenic mice. Nature genetics, 39 (7), 914–921.
   PubMed Web of Science ®Google Scholar
• Fan, F. and Wood, K.V., 2007. Bioluminescent assays for high-throughput screening. Assay and drug development technologies, 5 (1), 127–136.
   PubMed Web of Science ®Google Scholar
• Filleur, S., et al., 2003. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth. Cancer research, 63 (14), 3919–3922.
   PubMed Web of Science ®Google Scholar
• Ghildiyal, M. and Zamore, P.D., 2009. Small silencing RNAs: an expanding universe. Nature reviews genetics, 10 (2), 94–108.
   PubMed Web of Science ®Google Scholar
• Huang, Y., et al., 2008. PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides. Journal of materials science: materials in medicine, 19 (2), 607–614.
   PubMed Web of Science ®Google Scholar
• Huang, Y., et al., 2011. Polysorbate cationic synthetic vesicle for gene delivery. Journal of biomedical materials research Part A, 96A (3), 513–519.
   Web of Science ®Google Scholar
• Jackson, A.L. and Linsley, P.S., 2010. Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nature reviews drug discovery, 9 (1), 57–67.
   PubMed Web of Science ®Google Scholar
• Kanasty, R., et al., 2013. Delivery materials for siRNA therapeutics. Nature materials, 12 (11), 967–977.
   PubMed Web of Science ®Google Scholar
• Khalil, I.A., 2006. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacological reviews, 58 (1), 32–45.
   PubMed Web of Science ®Google Scholar
• Koltover, I., et al., 1998. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science (New York, N.Y.), 281 (5373), 78–81.
   PubMed Web of Science ®Google Scholar
• Li, S.-D., Chono, S., and Huang, L., 2008. Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles. Journal of controlled release, 126 (1), 77–84.
   PubMed Web of Science ®Google Scholar
• Manosroi, A., et al., 2011. In vitro and in vivo skin anti-aging evaluation of gel containing niosomes loaded with a semi-purified fraction containing gallic acid from Terminalia chebula galls. Pharmaceutical biology, 49 (11), 1190–1203.
   PubMed Web of Science ®Google Scholar
• Marianecci, C., et al., 2014. Niosomes from 80s to present: the state of the art. Advances in colloid and interface science, 205, 187–206.
   PubMed Web of Science ®Google Scholar
• Minakuchi, Y., 2004. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic acids research, 32 (13), e109–e109.
   PubMed Web of Science ®Google Scholar
• Moghassemi, S. and Hadjizadeh, A., 2014. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. Journal of controlled release: official journal of the controlled release SOCIETY, 185, 22–36.
   PubMed Web of Science ®Google Scholar
• Obeid, M.A., et al., 2017a. Comparison of the physical characteristics of monodisperse non-ionic surfactant vesicles (NISV) prepared using different manufacturing methods. International journal of pharmaceutics, 521 (1–2), 54–60.
   PubMed Web of Science ®Google Scholar
• Obeid, M.A., et al., 2017b. Delivering natural products and biotherapeutics to improve drug efficacy. Therapeutic delivery, 8 (11), 947–956.
   PubMed Web of Science ®Google Scholar
• Obeid, M.A., et al., 2017c. Formulation of non-ionic surfactant vesicles (NISV) prepared by microfluidics for therapeutic delivery of siRNA into cancer cells. Molecular pharmaceutics, 14 (7), 2450–2458.
   PubMed Web of Science ®Google Scholar
• Obeid, M.A., et al., 2017d. The effects of hydration media on the characteristics of non-ionic surfactant vesicles (NISV) prepared by microfluidics. International journal of pharmaceutics, 516 (1–2), 52–60.
   PubMed Web of Science ®Google Scholar
• Obeid, M.A., et al., 2018. Lipid-based nanoparticles for cancer treatment. In : A. M. Grumezescu, ed. Lipid nanocarriers for drug targeting. Elsevier, p. 313–359.
   Google Scholar
• Paecharoenchai, O., et al., 2013. Nonionic surfactant vesicles for delivery of RNAi therapeutics. Nanomedicine (London, England), 8 (11), 1865–1873.
   PubMed Web of Science ®Google Scholar
• Pardakhty, A., Varshosaz, J., and Rouholamini, A., 2007. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. International journal of pharmaceutics, 328 (2), 130–141.
   PubMed Web of Science ®Google Scholar
• Pawar, S. and Vavia, P., 2016. Glucosamine anchored cancer targeted nano-vesicular drug delivery system of doxorubicin. Journal of drug targeting, 24 (1), 68–79.
   PubMed Web of Science ®Google Scholar
• Pozzi, D., et al., 2010. Effect of cholesterol on the formation and hydration behavior of solid-supported niosomal membranes. Langmuir, 26 (4), 2268–2273. 2009.
   PubMed Web of Science ®Google Scholar
• Pozzi, D., et al., 2014. Mechanistic evaluation of the transfection barriers involved in lipid-mediated gene delivery: interplay between nanostructure and composition. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1838 (3), 957–967.
   PubMed Web of Science ®Google Scholar
• Ragelle, H., et al., 2014. Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency. Journal of controlled release, 176, 54–63.
   PubMed Web of Science ®Google Scholar
• Resnier, P., et al., 2013. A review of the current status of siRNA nanomedicines in the treatment of cancer. Biomaterials, 34 (27), 6429–6443.,
   PubMed Web of Science ®Google Scholar
• Reynolds, A., et al., 2004. Rational siRNA design for RNA interference. Nature biotechnology, 22 (3), 326.
   PubMed Web of Science ®Google Scholar
• Rungphanichkul, N., et al., 2011. Preparation of curcuminoid niosomes for enhancement of skin permeation. Die Pharmazie, 66 (8), 570–575.
   PubMed Web of Science ®Google Scholar
• Schroeder, A., et al., 2010. Lipid‐based nanotherapeutics for siRNA delivery. Journal of internal medicine, 267 (1), 9–21.
   PubMed Web of Science ®Google Scholar
• Siomi, M.C., 2009. Short interfering RNA-mediated gene silencing; towards successful application in human patients. Advanced drug delivery reviews, 61 (9), 668–671.
   PubMed Web of Science ®Google Scholar
• Takemoto, H., et al., 2010. Polyion complex stability and gene silencing efficiency with a siRNA-grafted polymer delivery system. Biomaterials, 31 (31), 8097–8105.
   PubMed Web of Science ®Google Scholar
• Tavano, L., et al., 2013. Doxorubicin loaded magneto-niosomes for targeted drug delivery. Colloids and surfaces. B, biointerfaces, 102, 803–807.
   PubMed Web of Science ®Google Scholar
• Whitehead, K.A., Langer, R., and Anderson, D.G., 2009. Knocking down barriers: advances in siRNA delivery. Nature reviews drug discovery, 8 (2), 129–138.
   PubMed Web of Science ®Google Scholar
• Zhou, C., et al., 2012. SPANosomes as delivery vehicles for small interfering RNA (siRNA). Molecular pharmaceutics, 9 (2), 201–210.
   PubMed Web of Science ®Google Scholar